Clinical Edge Journal Scan

Screening and management of comorbidities could help reduce preventable psoriasis hospitalizations


 

Key clinical point: Although rates of principal psoriasis hospitalizations have decreased among patients with psoriasis in the last 2 decades in the United States, hospitalization for non-psoriatic reasons has increased, which may be attributed to increased comorbidity burden driving admissions because of comorbidities.

Major finding: Between 1998 and 2018, the incidence of hospitalizations with either principal or secondary diagnosis of psoriasis increased from 17.9 to 52.0 per 100,000 persons, the proportion of patients with psoriasis hospitalized with psoriasis as principal diagnosis reduced from 4.1% to 1.0%, and those with Charlson Comorbidity Index score of 3 or higher increased from 13.9% to 30.9% (all adjusted P-trend < .0001).

Study details: This was a 21-year longitudinal trend analysis of the National Inpatient Sample database between 1998 and 2018 including adults with a principal or secondary diagnosis of psoriasis.

Disclosures: The study did not receive any funding. The authors declared no conflict of interests.

Source: Edigin E et al. J Eur Acad Dermatol Venereol. 2021 Aug 9. doi: 10.1111/jdv.17590 .

Recommended Reading

Bimekizumab approved in Europe for psoriasis treatment
MDedge Dermatology
Apremilast shows promise for mild-to-moderate psoriasis in phase 3
MDedge Dermatology
Risk for serious infection and biologics use in psoriasis: Is there a link?
MDedge Dermatology
Joint pain drives higher analgesic use in psoriasis
MDedge Dermatology
Emergence of cutaneous lymphoma needs special attention in patients with psoriasis
MDedge Dermatology
Subclinical liver disease tied to subclinical atherosclerosis in psoriasis
MDedge Dermatology
Plaque psoriasis: Substantial improvement in QoL with Cal/BD aerosol foam
MDedge Dermatology
Dimethyl fumarate seems to be effective and safe for management of psoriasis in the elderly
MDedge Dermatology
Proactive management of psoriasis with Cal/BD foam prolongs remission, regardless of patient baseline characteristics
MDedge Dermatology
Low hemoglobin elevates psoriasis risk in patients with chronic kidney disease
MDedge Dermatology